Alnylam Pharmaceuticals Inc (ALNY)
246.80
-1.99
(-0.80%)
USD |
NASDAQ |
Nov 21, 16:00
249.68
+2.88
(+1.17%)
After-Hours: 20:00
Alnylam Pharmaceuticals Debt to Equity Ratio: 31.64 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 31.64 |
| June 30, 2024 | -333.45 |
| March 31, 2024 | -4.660 |
| December 31, 2023 | -4.626 |
| September 30, 2023 | -6.148 |
| June 30, 2023 | -2.496 |
| March 31, 2023 | -3.926 |
| December 31, 2022 | -6.427 |
| September 30, 2022 | -15.02 |
| June 30, 2022 | 3.850 |
| March 31, 2022 | 1.687 |
| December 31, 2021 | 1.149 |
| September 30, 2021 | 0.5739 |
| June 30, 2021 | 0.5076 |
| March 31, 2021 | 0.2069 |
| December 31, 2020 | 0.1882 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0171 |
| March 31, 2019 | 0.0194 |
| December 31, 2018 | 0.023 |
| September 30, 2018 | 0.0203 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0185 |
| March 31, 2018 | 0.0171 |
| December 31, 2017 | 0.017 |
| September 30, 2017 | 0.1417 |
| June 30, 2017 | 0.1336 |
| March 31, 2017 | 0.1805 |
| December 31, 2016 | 0.163 |
| September 30, 2016 | 0.1478 |
| June 30, 2016 | 0.1366 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-333.45
Minimum
Jun 2024
31.64
Maximum
Sep 2024
-16.85
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7219 |
| BridgeBio Pharma Inc | -1.398 |
| Gilead Sciences Inc | 1.258 |
| Johnson & Johnson | 0.5096 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.205B |
| Total Liabilities (Quarterly) | 4.173B |
| Shareholders Equity (Quarterly) | 32.35M |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |